Concepedia

Doris K. Hansen

DK

Statistics

Publications

33

Citations

1.5K

H-Index

21

Active since

1951

Affiliations

Moffitt Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Levine Cancer Institute

Stanford University

Cleveland Clinic

Doris K. Hansen is an author at Moffitt Cancer Center specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

1951–2025

33

Publications

33

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Doris K. Hansen, Surbhi Sidana, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 279 citations · Full text

, , +15

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 124 citations · Full text

, , +14

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal et al. · Journal of Hematology & Oncology · 2023 · 117 citations · Full text

, , +17

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi et al. · Blood Cancer Journal · 2023 · 111 citations · Full text

, , +17

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi et al. · Blood Advances · 2022 · 99 citations · Full text

, , +14

1–5 of 33